What is the Biomedicine & Pharmacotherapy JIF?

The JIF is 6.7 (2024 JCR). See the full year-by-year trend and category ranking in our Biomedicine & Pharmacotherapy JIF analysis.

What is the acceptance rate of Biomedicine & Pharmacotherapy?

Manusights currently treats Selective Elsevier pharmacotherapy journal as an estimate for Biomedicine & Pharmacotherapy, not an official journal-published rate. One common reason papers fail is descriptive activity without mechanism.

How long does Biomedicine & Pharmacotherapy take to review?

Biomedicine & Pharmacotherapy typically takes Editorial screening first; peer review after editor fit, but timing varies by editor, field, and reviewer availability. Expect an editorial screen first, then scope fit, then peer review.

Is Biomedicine & Pharmacotherapy peer reviewed?

Yes, Biomedicine & Pharmacotherapy is fully peer reviewed. All submissions undergo rigorous peer review by Reviewers assess mechanism, controls, disease relevance, statistics, and claim discipline..

All Journal Guides

Journal Guide

Publishing in Biomedicine & Pharmacotherapy: Fit, Timeline & Submission Guide

Q: Is Biomedicine & Pharmacotherapy a good journal?

Biomedicine & Pharmacotherapy is a strong target if editors need to see how the manuscript advances therapeutic understanding, not only that a compound, pathway, or model produced a measurable effect. It is a weaker fit if activity data alone often reads as preliminary biology rather than pharmacotherapy.

Q: What does Biomedicine & Pharmacotherapy look for in submissions?

Pharmacotherapy contribution: Editors need to see how the manuscript advances therapeutic understanding, not only that a compound, pathway, or model produced a measurable effect.

Q: What should I know before submitting to Biomedicine & Pharmacotherapy?

Put the therapeutic decision in the first screen. The abstract and cover letter should say what the manuscript changes about treatment, mechanism, or drug-disease reasoning.

Biomedicine & Pharmacotherapy fits biomedical manuscripts where mechanism and translational therapeutic relevance are both visible.

Should you submit here?

Submit if editors need to see how the manuscript advances therapeutic understanding, not only that a compound, pathway, or model produced a measurable effect. Be careful if activity data alone often reads as preliminary biology rather than pharmacotherapy.

IF 6.7 · Selective Elsevier pharmacotherapy journal accepted · Editorial screening first; peer review after editor fit

Best fit if

Editors need to see how the manuscript advances therapeutic understanding, not only that a compound, pathway, or model produced a measurable effect

Not ideal if

Activity data alone often reads as preliminary biology rather than pharmacotherapy

Also compare

Scienceand IJMS

6.7

Impact Factor (2024)

Selective Elsevier pharmacotherapy journal

Acceptance Rate

Editorial screening first; peer review after editor fit

Time to First Decision

Readiness Scan

See whether your manuscript clears Biomedicine & Pharmacotherapy’s editorial screen.

Free 1 to 2 minute scan. Get a fit score, top issues, and the specific Biomedicine & Pharmacotherapy desk-reject patterns flagged before you submit.

Check my Biomedicine & Pharmacotherapy readiness See a sample report

Anthropic Privacy Partner. Zero-retention manuscript processing.

What Biomedicine & Pharmacotherapy Publishes

Biomedicine & Pharmacotherapy publishes original research and reviews across biomedicine and pharmacotherapy, with emphasis on drug mechanisms, therapeutic relevance, pharmacology, translational biology, and disease-linked biomedical evidence.

Pharmacotherapy studies where the therapeutic mechanism is visible in the abstract, figures, methods, and discussion
Biomedical research with in-vivo, translational, or clinically relevant evidence supporting the claim
Drug, natural-product, molecular, cellular, or disease-model work that advances a pharmacotherapy decision rather than only describing activity

Editor Insight

“Biomedicine & Pharmacotherapy readiness depends on whether the manuscript reads as a therapeutic contribution with enough mechanism and translational support, not only as a biomedical activity report.”

What Biomedicine & Pharmacotherapy Editors Look For

Pharmacotherapy contribution

Editors need to see how the manuscript advances therapeutic understanding, not only that a compound, pathway, or model produced a measurable effect.

Mechanistic support

The abstract, figures, methods, and controls should make the mechanism credible enough for reviewers to evaluate the therapeutic claim.

Translational evidence

In-vivo, disease-model, or clinically relevant support should match the strength of the pharmacotherapy conclusion.

Why Papers Get Rejected

These patterns appear repeatedly in manuscripts that don't make it past Biomedicine & Pharmacotherapy's editorial review:

Descriptive activity without mechanism

Activity data alone often reads as preliminary biology rather than pharmacotherapy.

Therapeutic claim exceeds evidence

A strong claim needs in-vivo, translational, or clinically relevant support that fits the disease context.

Cover letter frames pure biology

Editors should not have to infer the pharmacotherapy contribution from general biomedical language.

Does your manuscript avoid these patterns?

The Free Readiness Scan reads your full manuscript against Biomedicine & Pharmacotherapy's criteria and flags the specific issues most likely to cause rejection.

Run Free Readiness Scan →

Insider Tips from Biomedicine & Pharmacotherapy Authors

Put the therapeutic decision in the first screen

The abstract and cover letter should say what the manuscript changes about treatment, mechanism, or drug-disease reasoning.

Audit every main figure against the claim

The evidence package should not rely on supplementary material to carry the core pharmacotherapy story.

The Biomedicine & Pharmacotherapy Submission Process

Scope fit

Before upload

Confirm that the paper is pharmacotherapy-centered rather than only biomedical description.

Prepare Elsevier package

Pre-submission

Finalize manuscript, figures, declarations, ethics statements, data availability, and supplementary files.

Submit online

Day 0

Upload through Elsevier Editorial Manager following the live guide for authors.

Editorial assessment

Initial screen

Editors screen scope, mechanism, translational relevance, ethics, and reviewer fit.

Peer review

After editor invitation

Reviewers assess mechanism, controls, disease relevance, statistics, and claim discipline.

Biomedicine & Pharmacotherapy by the Numbers

Publisher	Elsevier
Core scope	Biomedicine and pharmacotherapy
Submission system	Elsevier Editorial Manager

Before you submit

Biomedicine & Pharmacotherapy accepts a small fraction of submissions. Make your attempt count.

Start with the Free Readiness Scan. Unlock the Full Review from $29, with local pricing shown before checkout. If you need deeper submission planning, choose the Submission-Ready Dossier. The full report is calibrated to Biomedicine & Pharmacotherapy.

Run Free Readiness Scan See a sample report

Article Types

Original Article

Original pharmacotherapy or biomedical research article

Review

Synthesis of biomedical and pharmacotherapy evidence

Landmark Biomedicine & Pharmacotherapy Papers

Papers that defined fields and changed science:

Pharmacotherapy mechanism studies
Disease-model therapeutic validation papers
Translational pharmacology reviews

Preparing a Biomedicine & Pharmacotherapy Submission?

Get pre-submission feedback from reviewers who've published in Biomedicine & Pharmacotherapy and know exactly what editors look for.

Run Free Readiness Scan

Need expert depth? See Expert Review Options

NDA-protected

Confidential

Primary Fields

PharmacotherapyBiomedical ScienceTranslational MedicinePharmacologyDisease Mechanisms

Ready to submit to Biomedicine & Pharmacotherapy?

A desk rejection costs months. Get expert feedback before you submit, from scientists who know exactly what Biomedicine & Pharmacotherapy editors look for.

Need field-expert depth? See Expert Review Options